Rajeev M. Shah
Sits on 26 boards. Overboarded · 26 public boards Last updated September 28, 2026
Time on boards
- Boards served
- 26
- Current seats
- 26
- Board service
- 65 years
- Director since
- 2023
65 years of board service in total across 26 boards, counting each seat separately. Longest: Werewolf Therapeutics Inc., 3 years.
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Aug 12, 2026 | Septerna Inc. | Open-market sale | −746,500 | $42.50 | $31,726,250 |
| Aug 12, 2026 | Septerna Inc. | Open-market sale | −746,500 | $42.50 | $31,726,250 |
| Jul 16, 2026 | Vor Biopharma Inc. | In-the-money exercise | +2,100,000 | — | — |
| Jul 16, 2026 | Vor Biopharma Inc. | Open-market sale | −213 | $19.75 | $4,207 |
| Jul 13, 2026 | Artiva Biotherapeutics Inc. | Open-market purchase | +6,552 | $8.94 | $58,575 |
| Jul 10, 2026 | Artiva Biotherapeutics Inc. | Open-market purchase | +15,102 | $8.97 | $135,465 |
| May 6, 2026 | Hemab Therapeutics Holdings Inc. | Open-market purchase | +14,611 | $23.77 | $347,303 |
| May 6, 2026 | Hemab Therapeutics Holdings Inc. | Open-market purchase | +53,407 | $24.83 | $1,326,096 |
| May 5, 2026 | Hemab Therapeutics Holdings Inc. | Open-market purchase | +87,143 | $24.59 | $2,142,846 |
| May 5, 2026 | Hemab Therapeutics Holdings Inc. | Open-market purchase | +10,268 | $25.00 | $256,700 |
| May 4, 2026 | Hemab Therapeutics Holdings Inc. | Derivative conversion | +3,607,846 | — | — |
| May 4, 2026 | Hemab Therapeutics Holdings Inc. | Derivative conversion | +1,009,052 | — | — |
| May 4, 2026 | Hemab Therapeutics Holdings Inc. | Derivative conversion | +221,188 | — | — |
| May 4, 2026 | Hemab Therapeutics Holdings Inc. | Open-market purchase | +2,541,250 | $18.00 | $45,742,500 |
| May 4, 2026 | Hemab Therapeutics Holdings Inc. | Open-market purchase | +133,750 | $18.00 | $2,407,500 |
Questions about Rajeev M. Shah
What boards is Rajeev M. Shah on?
Rajeev M. Shah sits on the boards of ARS Pharmaceuticals Inc., Acrivon Therapeutics Inc., Acumen Pharmaceuticals Inc., Artiva Biotherapeutics Inc., Bambusa Therapeutics Inc., Bicara Therapeutics Inc., Black Diamond Therapeutics Inc., Climb Bio Inc., Evommune Inc., Freenome Inc. and 16 others.
How long has Rajeev M. Shah served on boards?
Our records show at least 65 years of board service across 26 boards, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.